O&atives.
This atberectomy (37 f 16%. p < 0.001) and excimer laser aogioplasty (37 -C 16%, p < 0.001) and lower after Within the past 5 years sevsral new percutaneous interventional devices have been developed with the hope of addressing tht limitations of conventional balloon angioplasty. Despite the increasing availability of these new devices. adjunctive angioplasty is frequently required to optimize I;!.nen enlargement, manage device-induced complications or salvage procedural failures (1). There is widespread belief among many interventional cardiologists that better results are obtained by adjunctive angioplasty after atherectomy or cxcimer laser treatment compared with angioplasty alone. Although the concept of "debulking and dilating." '1~ "facilitated rngio- (.I Am Cdl GuuW 1996:27:552-9) plasty" is theoretically appealing. there are no data to support this common clinical practice. The purpose of this study was to determine i; adjunctive angioplasty after rotational atherectomy (Rotablator), extraction atherectomy and excimer laser angioplasty resulted in better lumen enlargement than angioplasty alone.
Methods
Study group.
Between October I988 and June 1994. percutaneous coronary interventions were perfomled on !,7ti native coronary artery lesions in 1210 patients with a mean (?SD) age of 62 z IO years. These interventions included angioplasty performed either alone (n = 511) or after consecutive extra&m a!herectomy (n = 37). rotational atherectomy (n = 11 I) or excimcr laser prlgioplasb (n = 37). Angiopl3sty wa\ used after 65% of extraction atherectomy procedure 9oci of rotational atherectomy procedures and 9% of excimer laser angiop&y procedures. The .mly specific guideline lor pfoiming ddjidri :'x +i@asty was to achieve a final diamc.er stenosis <.((F;. such d&tons were kft IO the discretion of the individual operators, who attempted to optimize immediate angiographic results by using an angioplasty balloon matched to the diameter of the vessel (i.e., balloon/artery ratio -1). Before approval by the U.S. Food and Drug Administration, atherectomy and laser procedures were performed according to protocols approved by the Human Investigations Committee of William Beaumont Hospital. The techniques of extraction atherectomy, rotational atherectomy and excimer laser angioplasty have been previously described (2) (3) (4) . and the immediate results, complications and foilow-up for rotational atherectomy and extraction atherectomy have been previously reported (23).
Amgiographie analysis. Detailed qualitative lesion morphologic analysis was performed as previously descriid (2.3). Quantitative angiographic analysis was performed immediately before and after each intervention using the single view which identified the most severe stenosis. Minimal lumen diameter and reference artery diameter were measured on projected images of selected optically magnified tine frames referenced to the known diameter of the angiographic catheter. All views were selected with the target lesion and reference guiding catheter in the same plane, maximally elongated and centered to reduce vessel foreshortening and pincushion distortion. Intracoionary nitroglycerin (0.1 to 1.0 mg) was routinely administered before and after each intervention. Before 1993, quantitative angiography waz performed using digital electronic calipers, as previously described (l-3,5), which provide excellent agreement with other computerized edge detection and densit>metric techniques over a wide range of arterial dimensions (6-8). Since 1993, quantitative angiography was performed using computerized edge detection (9). A subset of 100 lesions was analyzed by both techniques to establish their correlation.
Device size. The diameter of the device was assumed to be that specified by the manufacturer. For rotational atherectomy, excimer laser angioplasty and balloon angioplasty, the diameter of the device was recorded in mm. For extraction atherectomy. the diameter of the cutter (in mm) was calculated by dividing the French size of the device (reported by the manufacturer) by 3. In a subset of 500 lesions. inflated angioplasty balloon diameters were measured by computerized edge detection to determine the correlation between the measured and nominal balloon diameter.
Detinitioas. For purposes of the present study. baseline, re:idual and final data refer to those ilnmediately before inttrventionn; immediately after intervention with athercctomy. excin,er Iascr angioplasty or angioplasly alone: and after final angiography (including the use of adjunctive angioplasty after a device). respectively. Several indexes of devirr sizing and lumen enlargement were employed. The device or balloon sizing index was defined as the ratio of the final device diameter :3r balloon diameter to the normal reference diameter (device/artery ratio or balloon/artery ratio) to provide a measure of relative device sizing. as preGously de&bed (10,li Data presented are number (5) and by recently reported measures of efiency of lumen enlargement (11). The efficiency index was defined as the ratio of the final lumen diameter (FLD) to the final balloon diameter (B), which normalizes the final lumen diameter for balloon size and is a measure of efficiency of balloon-mediated lumen enlargement. When the balloon-sizing index (balloon! artery ratio) equals 1, the final lumen diameter equals (1 -FLD/B) X 100. Facilitated angioplasty was considered lo b?: present if the final diameter stenosis/balloon diameter ratio for adjunctive angioplzty atier laser or atherectomy was greater than angioplasly alone.
StaGstical analysis. Results are reported as mean value 2 SD. Comparisons were made using Student r test for continuous variables. and multiple comparisons were performed using analysis of variance. A p value < 0.05 was considered significant.
Results
Valid&to of aagiugrapbic sletbod. Because quantitative angiography was performed by two different methods. It was potentially important to determine their correlation. In MtJ lesions, lumen diameter (r = 0.74) and reference artery diameter were highly correlated (r = 0.70). rhere were no differences between methods with respect tC lumen diameter or reference vessel diameter. Therefore. the quantitative angiq;aphic results for both methods were ccmbined. In addition, maximal icflated balloon diameter was measured in 5(W1 lesions by computerized quantita!ive ,!ngiography. and was equal to 97% of nominal balloon diameters (p = NS). There was no difference (p = 0.55) between measured maximal bal!oon diameter and nominal balloon diameter. Therefore. nominal balloon diameter was used to calculate the eticiene of balloon-mediated lumen enlargement for all lesions.
Dcseriptiop d l&i Target lesions were located in the left main coronary artery (65). left anterior descending coronary artery (33%). left circvmtlex coronary artery (lick ) and righ coronaq artery (41%) ( Table   3 ) and device sizing index (Fig. 1B) lumen dimensions after 90% of rotational atherectomy, 85% of extraction athercctomy aqd 92% of excimer laser cases. Compared with angioplasty alone. final diameter stenosis (with or without adjunctive angioplasty) was lower after rotational atherectomy (27 ? 15%, p < O.OOl), but higher after extraction atherectomy (37 5 l6%, p < 0.001) and laser angioplasty (37 ?I 16%, p < 0.001) ( Fig. 2A) .
Efkiency of tmlloorkmediated lumen enlargement. Although these diameter stenoses are consistent with facilitated angioplasty after rotational atherectomy (but not after extraction atherectomy or laser) compared with angioplasty alone, there were significant differences in final balloon diameter (see Table 3 : and balloon-sizing index (Fig. 2B) . Thus, although the balloon-sizing index was within the generally accepkd range of 0.9 to 1.1 for conventional balloon angioplasty, the final diameter sienosis may have underestimated the extent of facilitated lumen erlargement for adjunctive angioplasty after these devices. To further correct for differences ;il balloonsizing index, the efficiency index was calculated for all lesions, which has been reported to be an ideal measure of efficiency of lumen eniargement (11).
Consiiring all lesiins together, the efficiency of balloon-me&ted Iumen enlargement was higher for adjunctive angio- plasty after rotational atherectomy than after angioplasty alone (Fig. 3) . The absolute incremental gam in lumen diameter for adjunctive angioplasty after rotational atherectomy was equivalent to 9% of the inflated balloon diameter compared with angioplasty alone (100 X [0.78 -0.69]), consistent with "facilitated angioplasty." The relative degree of facilitated lumen enlargement for adjunctive angioplasty after rotational atherectomy was 13% (0.78 -0.6910.69 x 100) ( Fig. 4) .
To determine I) the impact of lesion morphology on balloon-mediated lumen enlargement and 2) whether extraction atherectomy and excimer laser facilitated angioplasty, the balloon efficiency index was calculated for various lesion subsets. Lesion morphology was stratified according to the American College of Cardiology/American Heart Association classification (Table 4) : Compared with angioplasty alone, adjunct& angioplasty after excimer laser and rotational atherectomy had higher efficiency for type A lesions, adjunctive angioplasty after rotational atherectomy had higher efficiency for type B lesions, and adjuuctive angioplasty after laser and extraction atherectomy had lower ellkiency for type C lesions, whereas adjunctive angioplasty after rotational atherectomy was similar to angioplasty alone.
A potential shortcoming of this ABC classification is the inability to distinguish specific lesion morphologies. so the efficiency indexes were calculated for different lesion subsets (Table 4 ). For chronic total occlusions and lesions with thrombus, there was no evidence of facilitated lumen enlargement for adjunctive angioplasty after atherectomy or laser treatment, compared with angioplasty alone. For target lesions in vessels with minimal or no tortuosity. facilitated angioplasty was observed after rotational atherectomy. and for vessels with moderate tortuosity, adjunctive angioplasty after excimer laser treatment was significantly worse than angioplasty alone. A striking finding was the poor results of angioplasty alone for ostial lesions, for which adjunctive angioplasty after all atberectomy and laser devices resulted in signikantly better lumen enlargement. For eccentric lesions, ulcerated iesion~ calcified lesions, lesions with mild or moderate angulation and lesions >20 mm in length, adjunctive angioplasty after rotational atherectomy, but not after extraction atherectomy or excimer laser treatment, resulted in better lumen enlargement than angioplasty alone. The relative degree of facilitated lumen enlargement was greatest for ostial Icsions. for which tlrc rclativc improvement was -II% for rotational atherectomy and 22'; for extraction athcrcctomy and laser angioplasty. compared with angioplasty ;rlonc (Fig. 1) . The rclativc degree of lumen cnlargcment tin ,uljunctrvc angioplasty aticr rotational athercctomy was grcatcr than that of angioplasty alone for virtually all Icdon suhscts. although some cr thcsc diffcrcncc did not reach statistical significance (Fig. JA) . In contrast. the relative degree of lumen snlargcmcnt for adjunctivc angioplasty after extraction athcrectomy and cxcimcr laser angioplasty was highly variable (Fig. 4. B and C) . Angioplasty alone resulted in better lumen enlargement in 7 of IX morphologic categories compared with adjunctive angioplasty after extraction atherectomy.
and in 9 of lg morphologic categories compared with adjunctive angioplasty after excimer laser. although some of these differences did not reach statistical significance.
In particular, American College of Cardiology/American Heart Association type C Icsions had significanlly better lumen enlargement for angioplasty alone compared with adjunctive angioplasty after extraction atherectomy or rxcimcr laser angioplasty.
Discussion
Within the past 5 years thcrc has been intense interest in the dcvelopmcnt and application of new percutaneous interventional devices for the treatment of patients with ischemic heart disease. Several new atherectomy devices, lasers and stents have been approved by the U.S. Food and Drug Administration, allowing routine use of these new &vices for percutane nrs coronary revascularizal~on.
Role of new devices and angiopiasty. Some cardiologists have sugg:sted that angioplasty is limited in certain lesion subsets (o>tial lesions. diffuse disease, calcified lesions, chronic total :uzcosions and saphenous vein hypass grafts) (12, 13) . Although low profile balloon catheters, angled balloons, long hallmns and high pressure balloons may yield good acute angiographic results and acceptably low complications in such lesions (14-M). complex lesions remain problematic and are considered prime targets for new device application. Because some atherectomy and laser devices may fail to provide adequate lumen enlargement. adjunctive angioplasty is frequently used to optimize lumen diameter (I). In fact, adjunctive balloon angioplasty after successful (but suboptimal) directional atherectomy resulted in a final residual stenosis of 9%. without increasing the incidence of complications (19).
In the process of performing adjunctive angioplasty, some operatars have suggested that pretreatment with a new interventional device may actually "facilitate" the results of subsequent angioplasty. Although there are no published data to demonstrate that the combination of a device plus angioplasty is superior to angioplasty alone, this concept forms the basis for several randomized trials of directional and Rotablator atherectomy, which are now in progress Assessment of lumen enlargement. The following formula is commonly employed to calculate the final diameter stenosis after angioplasty: Cardiokw/Arwrican Heart Awciation Iniun cla&cation; ELCA = adjunctivc angiuplasry aHcr cxcimer law angioplasty; MRA = adJuncGw angioplasty after rotalinnal aihcrectcnuy; NA = not available: FTCA = anginplwry alone: TEC = adjuncrivc angiopl&y aficr sxt *iion athercebrny; TO = rdal trclusiun.
Final diameter stenosis (8) = (1 -[FLD/A])
x 100.
According to this equation, the final diameter stenosis is influenced by both the final lumen diameter (FLD) and the size of the reference segment (A). In tutu, the final lumen diameter depends on both the diameter of the final balloon and the efficiency al balloon-mediated lumen enlargement. The formula for final diameter stenosis can be written as follows:
Final diameter stenosis (%I = (I -[BIAPFLDIB])
In this equation, the final diameter stenosis is inversely related to the product of the balloon-sizing index (B/A ratio) and the balloon efficiency index (FLDIS ratio). Final diameter stenosis is thus suitable as a measure of balloon-dilating efficiency only if the balloon-sizing index is constant. Because the balloon-sizing indices for lesions treated with adjunctive angioplasty after rotational atherectomy, extraction atherectomy and laser were significantly less than angioplasly alone, that slight balloon undersizing may have underestimated the potential lumen enlargement for adjunctive angioplasty after these devices. Although all of the balloon-sizing indices were within the range (B/A = 0.9 lo 1.1) commonly employed for conventional angioplasty (10,1120), these significant differences make it diicult to draw firm conclusions about facilitated angioplasty based on the conventional criterion of final diameter stenosis. Evidence for facilitated aagioplrsty. Facilitated angioplasly is the concept that adjunclive angioplasty after another device provides a larger lumen than conventional angioplasly alone. Although one can argue that small improvements in the acute angiographic result might be simply cosmetic, the final lumen diameter after intervention is the most important determinant of late outcome and restenosis (5.21). Unlike final lumen diameter and final diameter stenosis, the balloon efficiency index (FLD/B ratio) provides an index of acute lumen enlargement that corrects for differences in balloon diameter, reference vessel diameter and device size, making it the best measure of etliciency of lumen enlargement.
This study supports the concept of facilitated angioplasty. Importantly. the extent of facilitated angioplasty wti dependent on the type of interventional device (balloon. laser, atherectomy device) and the morphology of the target lesion (Table 4 , Fig. 4 ). The degree of facililated angioplasty was greatest for o&al l&ins, for which angioplasty alone achieved poor lumen enlargement (FLD/B ratio 0.58). These data are consistent with the impression of many interventional cardiologists that ostial lesions respond poorly to balloon angiopiasty alone, and justiry interest in the application of new technologies to revascularize such lesions. compared with a@o@sty alone, there was facilitated angioplasty only after rotational atberectomy for ulcerated, eccentric and cabSed lesion% lesionsinamildormoderatcbend,andlesions>20mmia
